Somebody else pays first: management describes counterparties putting their own money down ahead of delivery
The model's full reasoning — Q3 2023 call → NOWe need to determine if management describes counterparties putting their own money/resources at risk before receiving what they are paying for, as something happening now. Look for mentions of prepayments, deposits, advances, etc. The transcript mentions APAs (advance purchase agreements). These are agreements where customers commit to purchase doses in advance. The company receives revenue from these APAs. The question: does management describe that counterparties are pre-funding the company? APAs are advance purchase agreements, meaning customers commit to buy in advance. But does that mean they pay in advance? Typically, APAs are contracts for future delivery, but payment may be upon delivery. The transcript says "committed dose deliveries" and "APA contract value" and "secured orders". It doesn't explicitly say customers pay in advance. It says "we expect to deliver all of the contracted doses" and "revenue recognition" tied to delivery. So it's not clear that customers pay before delivery. The question asks if counterparties are putting their own money at risk before receiving what they pay for. That would be like prepayment. The transcript does not mention customers paying in advance. It mentions "advance purchase agreements" but that's about committing to purchase, not necessarily paying in advance. Also, the company has grants and royalties, but those are from government, not commercial counterparties. The question specifically says "commercial counterparties". The APAs are with governments and organizations, but they are still counterparties. However, the key is whether they pay in advance. The transcript does not indicate that. It says "committed dose deliveries" and "revenue recognition" upon delivery. So no evidence of pre-funding. Also, the company is reducing costs and has cash from APAs, but that's future revenue. The question asks if management describes that counterparties are putting their own money at risk before delivery. I don't see that. There is mention of "APA contract value post the 2023-‘24 season deliveries" meaning after deliveries. So it's not pre-funding. Also, the company has "cash accounts receivable" which is money owed, not received. So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PDS | Precision Drilling Corporation | Q1 2024 | 2024-04-25 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| BLZE | Backblaze, Inc. | Q3 2022 | 2022-11-11 | D |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| EEX | Emerald Holding, Inc. | Q2 2021 | 2021-08-01 | C+ |
| SRDX | Surmodics, Inc. | Q3 2018 | 2018-08-06 | A |
| ROP | Roper Technologies, Inc. | Q2 2018 | 2018-07-26 | A |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| WYY | WidePoint Corporation | Q3 2016 | 2016-11-09 | D |
SYM · Q3 2022 → YESThe question is: Does management describe that the people on the OTHER SIDE of the company's business are now PUTTING THEIR OWN MONEY OR RESOURCES AT RISK BEFORE they receive what they are paying for ...YES The transcript shows management describing real advance commitments from customers: the $11.3 billion backlog (more than doubled), strong deferred revenue on the balance sheet representing a "very significant cost float," and contracts that lock in commitments with restricted changes. Revenue is recognized on a percentage-of-completion basis during deployment, meaning payments 18 months ahead of acceptance. This is framed as an active benefit enabling confident scaling, not a routine or historical norm. They also note improved supplier terms, but the customer-side pre-funding via deferred revenue and backlog is explicitly highlighted as occurring now. This meets the criteria for counterparties committing capital ahead of delivery.
EVGO · Q2 2022 → YESThe question is: Does management describe that the people on the OTHER SIDE of the company's business are now PUTTING THEIR OWN MONEY OR RESOURCES AT RISK BEFORE they receive what they are paying for ...YES The transcript shows management describing the eXtend model with Pilot and GM where the customer (Pilot/GM) incurs the upfront capital expenditures for the charging infrastructure, while EVgo receives ongoing revenues from operations, maintenance, and services. This is presented as an actual, current business arrangement that provides EVgo with immediate cash flow and contracted revenues, not as a future hope or industry norm. Cathy Zoi notes the agreement exceeds IRR hurdles and provides near-term revenue, and Olga Shevorenkova explains the customer funds the build-out, enabling EVgo to generate margin as developer and operator.
BLZE · Q3 2022 → YESThe question is: Does management describe that the people on the OTHER SIDE of the company's business are now PUTTING THEIR OWN MONEY OR RESOURCES AT RISK BEFORE they receive what they are paying for ...YES The transcript shows management describing B2 Reserve as a capacity-based pricing program that includes premium support and free data migration, with revenue ramping in Q3. Frank notes B2 Reserve contracts are "effectively committed contracts," and Gleb calls them "committed contracts" in response to an investor question. This is presented as occurring now, with "initial ramp in demand" and "revenue increasing each month of Q3," not as a future plan or industry norm. The capacity-reservation aspect aligns with the described phenomenon of counterparties committing capital in advance.